ATLANTA, GA – – (Businesswire – February 6, 2019) – – Holzer & Holzer, LLC is investigating whether certain statements made by Natus Medical, Inc. (“Natus Medical” or the “Company”) (NASDAQ: BABY) complied with federal securities laws. On February 6, 2019, the price of Natus Medical shares fell significantly following a short seller report accusing the Company of deceptive accounting practices. If you purchased Natus Medical shares and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at firstname.lastname@example.org or Marshall P. Dees, Esq. at email@example.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.